GlassScriptPhysician profile
Michael David Berger
NPI 1720460678
$5,019.66
in general payments reported to CMS, 2019-2025
14 companies · $1,869 in 2025
The $1,869 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2022: $12.89 · 2024: $2,151 · 2025: $1,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,330 · Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,330.35 |
| Food and Beverage | $1,689.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $986.96 | 2019 | |
| Arthrex, INC. | $913.09 | 2024-2025 | |
| Paragon 28, INC. | $793.25 | 2024 | Hammertube Sterile Implant Kits |
| Native Surgical, LLC | $706.98 | 2025 | |
| Supreme Orthopedic Systems, LLC | $395.12 | 2024 | |
| Integra Lifesciences Corporation | $351.66 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $332.55 | 2024-2025 | |
| Medartis INC. | $145.99 | 2025 | Aptus |
| Reflow Medical INC | $117.90 | 2025 | |
| Abbott Laboratories | $109.78 | 2025 | Esprit |
| Treace Medical Concepts, INC. | $59.36 | 2025 | |
| Organogenesis INC. | $47.99 | 2024-2025 | Affinity, Puraply Wound Matrix |
| Terumo Medical Corporation | $46.14 | 2025 | Glidewire, Angio-Seal, R2p Misago |
| Tactile Systems Technology INC | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.